Supply constraints push EpiPen rival maker Amneal to restructure, shares fall

Amneal Pharmaceuticals, which sells a generic epinephrine auto-injector similar to Mylan’s flagship Epipen, has initiated a sweeping restructuring of its business driven primarily by the uncertainty surrounding the supply of the emergency shot.